Clinical Microbiology and Infection

Article	Citations
Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis	994
COVID-19, SARS and MERS: are they closely related?	763
Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study	583
Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review	566
Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis	507
Follow-up of adults with noncritical COVID-19 two months after symptom onset	495
Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting	467
Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study	463
Risk factors for disease severity, unimprovement, and mortality in COVID-19 patients in Wuhan, China	431
Rapid and visual detection of 2019 novel coronavirus (SARS-CoV-2) by a reverse transcription loop-mediated isothermal amplification assay	420
European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society	353
Clinical characteristics of asymptomatic and symptomatic patients with mild COVID-19	282
Novel SARS-CoV-2 variants: the pandemics within the pandemic	271
SARS-CoV-2 seroprevalence worldwide: a systematic review and meta-analysis	263
COVID-19 pandemic—a focused review for clinicians	262
Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis	260
European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults	254
BNT162b2 vaccine breakthrough: clinical characteristics of 152 fully vaccinated hospitalized COVID-19 patients in Israel	248
COVID-19: don't neglect antimicrobial stewardship principles!	246
Saliva sample as a non-invasive specimen for the diagnosis of coronavirus disease 2019: a cross-sectional study	235
A multicentre observational study on the epidemiology, risk factors, management and outcomes of mucormycosis in India	233
Female gender is associated with long COVID syndrome: a prospective cohort study	230
Machine learning for clinical decision support in infectious diseases: a narrative review of current applications	228
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors	223
Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain	217

Impact of COVID-19 on maternal and neonatal outcomes: a systematic review and meta-analysis	209
Field evaluation of a rapid antigen test (Panbio™ COVID-19 Ag Rapid Test Device) for COVID-19 diagnosis in primary healthcare centres	203
Diagnostic performance of seven rapid IgG/IgM antibody tests and the Euroimmun IgA/IgG ELISA in COVID-19 patients	202
Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients	196
Effect of hydroxychloroquine with or without azithromycin on the mortality of coronavirus disease 2019 (COVID-19) patients: a systematic review and meta-analysis	193
Viable SARS-CoV-2 in various specimens from COVID-19 patients	178
Antibody response to SARS-CoV-2 mRNA vaccine among kidney transplant recipients: a prospective cohort study	169
Primary HPV-based cervical cancer screening in Europe: implementation status, challenges, and future plans	166
Umifenovir treatment is not associated with improved outcomes in patients with coronavirus disease 2019: a retrospective study	165
Clinical characteristics of non-critically ill patients with novel coronavirus infection (COVID-19) in a Fangcang Hospital	158
Large-scale implementation of pooled RNA extraction and RT-PCR for SARS-CoV-2 detection	149
Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine breakthrough infections: a multicentre cohort study	144
Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis	140
Recommendations for antibacterial therapy in adults with COVID-19 – an evidence based guideline	139
Pathogenesis and management of fracture-related infection	135
Accuracy of a nucleocapsid protein antigen rapid test in the diagnosis of SARS-CoV-2 infection	133
Validation of a commercially available SARS-CoV-2 serological immunoassay	132
Definitions for coronavirus disease 2019 reinfection, relapse and PCR re-positivity	129
Diagnostic strategies for SARS-CoV-2 infection and interpretation of microbiological results	127
2020 list of human papillomavirus assays suitable for primary cervical cancer screening	124
Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in people living with HIV-1	123
Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients—a multinational observational study by the European Confederation of Medical Mycology	123
Immunological and clinical efficacy of COVID-19 vaccines in immunocompromised populations: a systematic review	122
Post–COVID-19 chronic symptoms: a postinfectious entity?	118
How to interpret MICs of antifungal compounds according to the revised clinical breakpoints v. 10.0 European committee on antimicrobial susceptibility testing (EUCAST)	117
Outbreak of Candida auris infection in a COVID-19 hospital in Mexico	116
Antibody response against SARS-CoV-2 spike protein and nucleoprotein evaluated by four automated immunoassays and three ELISAs	116
Severe acute respiratory syndrome coronavirus 2 RNA contamination of inanimate surfaces and virus viability in a health care emergency unit	115
Anosmia in COVID-19 patients	113
Machine learning for microbial identification and antimicrobial susceptibility testing on MALDI-TOF mass spectra: a systematic review	106
ESCMID COVID-19 living guidelines: drug treatment and clinical management	103
Ibuprofen use and clinical outcomes in COVID-19 patients	103
Oral amoxicillin and amoxicillin–clavulanic acid: properties, indications and usage	102
Evaluation of a rapid antigen test (Panbio™ COVID-19 Ag rapid test device) for SARS-CoV-2 detection in asymptomatic close contacts of COVID-19 patients	102
Understanding the role of bacterial and fungal infection in COVID-19	101
A whole blood test to measure SARS-CoV-2-specific response in COVID-19 patients	98
Detection and infectivity potential of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) environmental contamination in isolation units and quarantine facilities	98
Clinical characteristics of ambulatory and hospitalized patients with monkeypox virus infection: an observational cohort study	97
Antibody persistence in the first 6 months following SARS-CoV-2 infection among hospital workers: a prospective longitudinal study	96
Antibody responses to BNT162b2 mRNA COVID-19 vaccine and their predictors among healthcare workers in a tertiary referral hospital in Japan	96
The role of asymptomatic and pre-symptomatic infection in SARS-CoV-2 transmission—a living systematic review	95
How to interpret and use COVID-19 serology and immunology tests	95
The interface between COVID-19 and bacterial healthcare-associated infections	94
Stigma at the time of the COVID-19 pandemic	93
Quantitative SARS-CoV-2 anti-spike responses to Pfizer–BioNTech and Oxford–AstraZeneca vaccines by previous infection status	93
Association of COVID-19 with pregnancy outcomes in health-care workers and general women	92
Risk factors for disease progression in patients with mild to moderate coronavirus disease 2019—a multi-centre observational study	92
Risk factors associated with COVID-19-associated pulmonary aspergillosis in ICU patients: a French multicentric retrospective cohort	92
Clinical evaluation of serological IgG antibody response on the Abbott Architect for established SARS-CoV-2 infection	91
Global prevalence of latent toxoplasmosis in pregnant women: a systematic review and meta-analysis	89

Current landscape in the discovery of novel antibacterial agents	89
Persistent COVID-19 symptoms are highly prevalent 6 months after hospitalization: results from a large prospective cohort	88
Clinical course and factors associated with outcomes among 1904 patients hospitalized with COVID-19 in Germany: an observational study	88
Clostridium difficile and One Health	88
Nationwide effectiveness of five SARS-CoV-2 vaccines in Hungary—the HUN-VE study	87
Risk factors for chronic biofilm-related infection associated with implanted medical devices	85
How do I manage nocardiosis?	84
Commercially available molecular tests for human papillomaviruses: a global overview	84
Molecular characterization of SARS-CoV-2 from the first case of COVID-19 in Italy	84
Neurologic manifestations associated with COVID-19: a multicentre registry	83
Incidence of invasive pulmonary aspergillosis among critically ill COVID-19 patients	83
Clinical course and outcomes of critically ill patients with COVID-19 infection: a systematic review	83
Pulmonary long-term consequences of COVID-19 infections after hospital discharge	83
Evolution of viral quasispecies during SARS-CoV-2 infection	83
Characteristics of 1573 healthcare workers who underwent nasopharyngeal swab testing for SARS-CoV-2 in Milan, Lombardy, Italy	81
Follow-up of asymptomatic patients with SARS-CoV-2 infection	80
Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19)	78
Challenges and issues about organizing a hospital to respond to the COVID-19 outbreak: experience from a French reference centre	77
Staphylococcus aureus bacteraemia mortality: a systematic review and meta-analysis	76
Serious bradycardia and remdesivir for coronavirus 2019 (COVID-19): a new safety concerns	75
Review of trials currently testing treatment and prevention of COVID-19	74
An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19	74
Clinical characteristics, management and in-hospital mortality of patients with coronavirus disease 2019 in Genoa, Italy	73
Diagnostic accuracy of serum (1-3)-β-D-glucan for Pneumocystis jirovecii pneumonia: a systematic review and meta-analysis	71
Early diagnosis and rapid isolation: response to COVID-19 outbreak in Korea	71
Onset, duration and unresolved symptoms, including smell and taste changes, in mild COVID-19 infection: a cohort study in Israeli patients	70
Excretion of SARS-CoV-2 in human breast milk	70
Performance of a novel diagnostic assay for rapid SARS-CoV-2 antigen detection in nasopharynx samples	69
ESCMID rapid guidelines for assessment and management of long COVID	68
Cardiac sequelae after coronavirus disease 2019 recovery: a systematic review	67
New-onset anosmia and ageusia in adult patients diagnosed with SARS-CoV-2 infection	67
Pre-exposure prophylaxis with tixagevimab and cilgavimab (Evusheld) for COVID-19 among 1112 severely immunocompromised patients	66
Machine learning in the clinical microbiology laboratory: has the time come for routine practice?	65
Antifungal therapeutic drug monitoring: focus on drugs without a clear recommendation	65
Investigating the impact of COVID-19 on primary care antibiotic prescribing in North West London across two epidemic waves	65
Multicenter evaluation of the Panbio™ COVID-19 rapid antigen-detection test for the diagnosis of SARS-CoV-2 infection	65
Machine learning in infection management using routine electronic health records: tools, techniques, and reporting of future technologies	64
Risk factors for carbapenem-resistant Gram-negative bacterial infections: a systematic review	63
Treatment of COVID-19 with convalescent plasma: lessons from past coronavirus outbreaks	62
Comparison of diagnostic accuracies of rapid serological tests and ELISA to molecular diagnostics in patients with suspected coronavirus disease 2019 presenting to the hospital	62
Efficacy of favipiravir in adults with mild COVID-19: a randomized, double-blind, multicentre, placebo-controlled clinical trial	61
Impact of time to antibiotic therapy on clinical outcome in patients with bacterial infections in the emergency department: implications for antimicrobial stewardship	60
Nucleic acid amplification tests on respiratory samples for the diagnosis of coronavirus infections: a systematic review and meta-analysis	59
Seven-versus 14-day course of antibiotics for the treatment of bloodstream infections by Enterobacterales: a randomized, controlled trial	59
Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-CoV-2 infection: a multicentre cohort study (PREDI-CO study)	58
Predictors of progression from moderate to severe coronavirus disease 2019: a retrospective cohort	57
Has the mortality from pulmonary mucormycosis changed over time? A systematic review and meta-analysis	57
Dynamic SARS-CoV-2-specific B-cell and T-cell responses following immunization with an inactivated COVID-19 vaccine	57
Long COVID-19—it's not over until?	56
Antibiotic resistance associated with the COVID-19 pandemic: a systematic review and meta-analysis	56
Differences in environmental stability among SARS-CoV-2 variants of concern: both omicron BA.1 and BA.2 have higher stability	55
Corticosteroid administration for viral pneumonia: COVID-19 and beyond	54
Cross-resistance to cefiderocol and ceftazidime–avibactam in KPC β-lactamase mutants and the inoculum effect	54
Systematic review on estimated rates of nephrotoxicity and neurotoxicity in patients treated with polymyxins	53
Rapid microbiological tests for bloodstream infections due to multidrug resistant Gram-negative bacteria: therapeutic implications	53
Antimicrobial susceptibility testing of Mycobacterium tuberculosis complex isolates – the EUCAST broth microdilution reference method for MIC determination	53
Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicentre study	52
Virus shedding dynamics in asymptomatic and mildly symptomatic patients infected with SARS-CoV-2	52
Molecular characterization of SARS-CoV-2 in the first COVID-19 cluster in France reveals an amino acid deletion in nsp2 (Asp268del)	52
Serology anno 2021—fungal infections: from invasive to chronic	52
SARS-CoV-2 ACE-receptor detection in the placenta throughout pregnancy	52
CT lung lesions as predictors of early death or ICU admission in COVID-19 patients	51
The potential clinical utility of measuring severe acute respiratory syndrome coronavirus 2-specific T-cell responses	51
Exposure to World Health Organization's AWaRe antibiotics and isolation of multidrug resistant bacteria: a systematic review and meta-analysis	51
Long-term persistence of olfactory and gustatory disorders in COVID-19 patients	51
Early antibody response in health-care professionals after two doses of SARS-CoV-2 mRNA vaccine (BNT162b2)	50
Effects of tocilizumab on mortality in hospitalized patients with COVID-19: a multicentre cohort study	50
Invasive pulmonary fusariosis in an immunocompetent critically ill patient with severe COVID-19	50
Acute kidney injury following the concurrent administration of antipseudomonal β-lactams and vancomycin: a network meta-analysis	50
SARS-CoV-2 specific T-cell immunity in COVID-19 convalescent patients and unexposed controls measured by ex vivo ELISpot assay	50
High-volume culture and quantitative real-time PCR for the detection of Aspergillus in sputum	49
How to: perform antifungal susceptibility testing of microconidia-forming dermatophytes following the new reference EUCAST method E.Def 11.0, exemplified by Trichophyton	49
Early detection of SARS-CoV-2 infection cases or outbreaks at nursing homes by targeted wastewater tracking	49
Culture-independent detection systems for bloodstream infection	49
Voriconazole plus terbinafine combination antifungal therapy for invasive Lomentospora prolificans infections: analysis of 41 patients from the FungiScope® registry 2008–2019	48
Disappearance of antibodies to SARS-CoV-2 in a -COVID-19 patient after recovery	48
Detection of multiple hypervirulent Klebsiella pneumoniae strains in a New York City hospital through screening of virulence genes	48
Estimating daily antibiotic harms: an umbrella review with individual study meta-analysis	48
Remdesivir for the treatment of COVID-19: a systematic review and meta-analysis	47
Real-world safety data for the Pfizer BNT162b2 SARS-CoV-2 vaccine: historical cohort study	47

Socioeconomic disparities and COVID-19 vaccination acceptance: a nationwide ecologic study	47
Invasive aspergillosis in patients with severe COVID-19 pneumonia	46
Update on SARS-CoV-2 seroprevalence: regional and worldwide	46
Specificity and positive predictive value of SARS-CoV-2 nucleic acid amplification testing in a low-prevalence setting	46
Prolonged SARS-CoV-2 cell culture replication in respiratory samples from patients with severe COVID-19	45
Safety considerations for chloroquine and hydroxychloroquine in the treatment of COVID-19	45
The kinetics of viral load and antibodies to SARS-CoV-2	45
Defining COVID-19–associated pulmonary aspergillosis: systematic review and meta-analysis	45
Antibiotic use in the COVID-19 crisis in Spain	44
Colistin plus meropenem for carbapenem-resistant Gram-negative infections: in vitro synergism is not associated with better clinical outcomes	44
Antibody response induced by the BNT162b2 mRNA COVID-19 vaccine in a cohort of health-care workers, with or without prior SARS-CoV-2 infection: a prospective study	44
Highly sensitive and specific detection of hepatitis B virus DNA and drug resistance mutations utilizing the PCR-based CRISPR-Cas13a system	44
Multicentric evaluation of BioFire FilmArray Pneumonia Panel for rapid bacteriological documentation of pneumonia	43
Predictors and microbiology of respiratory and bloodstream bacterial infection in patients with COVID-19: living rapid review update and meta-regression	42
Lower respiratory tract infection in the community: associations between viral aetiology and illness course	42
Non-invasive saliva specimens for the diagnosis of COVID-19: caution in mild outpatient cohorts with low prevalence	42
Antibiotics versus no therapy in kidney transplant recipients with asymptomatic bacteriuria (BiRT): a pragmatic, multicentre, randomized, controlled trial	42
Clinical evidence for repurposing chloroquine and hydroxychloroquine as antiviral agents: a systematic review	42
Co-infection with other respiratory pathogens in COVID-19 patients	41
Effectiveness of mRNA-BNT162b2, mRNA-1273, and ChAdOx1 nCoV-19 vaccines against COVID-19 in healthcare workers: an observational study using surveillance data	41
The seroprevalence of SARS-CoV-2 antibodies among health care workers before the era of vaccination: a systematic review and meta-analysis	41
Timing of SARS-CoV-2 vaccination during the third trimester of pregnancy and transplacental antibody transfer: a prospective cohort study	41
Self-testing for the detection of SARS-CoV-2 infection with rapid antigen tests for people with suspected COVID-19 in the community	41
Multiple-centre clinical evaluation of an ultrafast single-tube assay for SARS-CoV-2 RNA	41
Detection of SARS-CoV-2 N-antigen in blood during acute COVID-19 provides a sensitive new marker and new testing alternatives	41
Molecular analysis of clinical isolates of ceftazidime-avibactam-resistant Klebsiella pneumoniae	40
Bacillus Calmette-Guérin vaccine to reduce healthcare worker absenteeism in COVID-19 pandemic, a randomized controlled trial	39
Early outcome and safety of bedaquiline-containing regimens for treatment of MDR- and XDR-TB in China: a multicentre study	39
The WHO essential medicines list AWaRe book: from a list to a quality improvement system	39
Positive follow-up blood cultures identify high mortality risk among patients with Gram-negative bacteraemia	38
Prevalence of SARS-CoV-2 IgG antibodies in an area of northeastern Italy with a high incidence of COVID-19 cases: a population-based study	38
Quantifying the transmission of antimicrobial resistance at the human and livestock interface with genomics	38
Microbiology of hip and knee periprosthetic joint infections: a database study	38
Saliva for molecular detection of SARS-CoV-2 in school-age children	38
Obesity, diabetes, hypertension and severe outcomes among inpatients with coronavirus disease 2019: a nationwide study	38
Image analysis and artificial intelligence in infectious disease diagnostics	38
Silent spread of mobile colistin resistance gene mcr-9.1 on IncHI2 ‘superplasmids’ in clinical carbapenem-resistant Enterobacterales	36
Comparison of disk diffusion, MIC test strip and broth microdilution methods for cefiderocol susceptibility testing on carbapenem-resistant enterobacterales	36
Invasive infections with Fusobacterium necrophorum including Lemierre's syndrome: an 8-year Swedish nationwide retrospective study	36
Therapeutic strategies for severe COVID-19: a position paper from the Italian Society of Infectious and Tropical Diseases (SIMIT)	36
SARS-CoV-2 N gene dropout and N gene Ct value shift as indicator for the presence of B.1.1.7 lineage in a commercial multiplex PCR assay	36
Predicting Pseudomonas aeruginosa susceptibility phenotypes from whole genome sequence resistome analysis	36
Assessment of prevalence and load of torquetenovirus viraemia in a large cohort of healthy blood donors	36
Molecular diagnosis of polymicrobial brain abscesses with 16S-rDNA-based next-generation sequencing	36
Persistence of anti-SARS-CoV-2 antibodies: immunoassay heterogeneity and implications for serosurveillance	35
Daptomycin in the treatment of enterococcal bloodstream infections and endocarditis: a EUCAST position paper	35
Personal protective equipment protecting healthcare workers in the Chinese epicentre of COVID-19	35
Safety and immunogenicity of SpikoGen®, an Advax-CpG55.2-adjuvanted SARS-CoV-2 spike protein vaccine: a phase 2 randomized placebo-controlled trial in both seropositive and seronegative populations	35
Elevation of serum ferritin levels for predicting a poor outcome in hospitalized patients with influenza infection	35
Pseudomonas aeruginosa and lung function decline in patients with bronchiectasis	35
Prevalence and factors associated with SARS-CoV-2 seropositivity in the Spanish HIV Research Network Cohort	34
Dynamics and predisposition of respiratory viral co-infections in children and adults	34
A host signature based on TRAIL, IP-10, and CRP for reducing antibiotic overuse in children by differentiating bacterial from viral infections: a prospective, multicentre cohort study	34
An update on Toscana virus distribution, genetics, medical and diagnostic aspects	34
Pretomanid for tuberculosis: a systematic review	34
Emerging non-13-valent pneumococcal conjugate vaccine (PCV13) serotypes causing adult invasive pneumococcal disease in the late-PCV13 period in Spain	33
Fangcang shelter hospitals in COVID-19 pandemic: the practice and its significance	33
Infections caused by extended-spectrum β-lactamase-producing Enterobacterales after rectal colonization with ESBL-producing Escherichia coli or Klebsiella pneumoniae	33
Community-acquired bacterial meningitis in adults: in-hospital prognosis, long-term disability and determinants of outcome in a multicentre prospective cohort	33
COVID-19-associated pulmonary aspergillosis (CAPA): how big a problem is it?	33
Pharmacokinetics/pharmacodynamics of antipseudomonal bacteriophage therapy in rats: a proof-of-concept study	33
In vivo emergence of high-level resistance during treatment reveals the first identified mechanism of amphotericin B resistance in Candida auris	33
Fluconazole-resistant Candida parapsilosis clonally related genotypes: first report proving the presence of endemic isolates harbouring the Y132F ERG11 gene substitution in Spain	33
Clinical outcomes of the severe acute respiratory syndrome coronavirus 2 Omicron and Delta variant: systematic review and meta-analysis of 33 studies covering 6 037 144 coronavirus disease 2019–positi	32
Antibiotic treatment for 6 days versus 12 days in patients with severe cellulitis: a multicentre randomized, double-blind, placebo-controlled, non-inferiority trial	32
National surveillance of bacterial and fungal coinfection and secondary infection in COVID-19 patients in England: lessons from the first wave	32
Resistance mutations in SARS-CoV-2 omicron variant in patients treated with sotrovimab	32
Clinical outcome in solid organ transplant recipients affected by COVID-19 compared to general population: a systematic review and meta-analysis	32
Dramatically improved hand hygiene performance rates at time of coronavirus pandemic	32
Saliva collected in universal transport media is an effective, simple and high-volume amenable method to detect SARS-CoV-2	32
Epidemiology, evolution and cryptic susceptibility of methicillin-resistant Staphylococcus aureus in China: a whole-genome-based survey	32
Post–COVID-19 syndrome and humoral response association after 1 year in vaccinated and unvaccinated patients	32
How do I manage a patient with enterococcal bacteraemia?	32
Mandatory surveillance and outbreaks reporting of the WHO priority pathogens for research & discovery of new antibiotics in European countries	32
Aminoglycosides for infective endocarditis: time to say goodbye?	32
Non-occupational and occupational factors associated with specific SARS-CoV-2 antibodies among hospital workers – A multicentre cross-sectional study	31
Rate and severity of suspected SARS-Cov-2 reinfection in a cohort of PCR-positive COVID-19 patients	31
Disinfectant effectiveness against SARS-CoV-2 and influenza viruses present on human skin: model-based evaluation	31
Public opinion on a mandatory COVID-19 vaccination policy in France: a cross-sectional survey	31
The impact of COVID-19 on community antibiotic use in Canada: an ecological study	31
Epidemiological and clinical characteristics of SARS-CoV-2 infections at a testing site in Berlin, Germany, March and April 2020—a cross-sectional study	31
How to design a study to evaluate therapeutic drug monitoring in infectious diseases?	31
Diagnostic accuracy of loop-mediated isothermal amplification coupled to nanopore sequencing (LamPORE) for the detection of SARS-CoV-2 infection at scale in symptomatic and asymptomatic populations	31
Low-to-moderate dose corticosteroids treatment in hospitalized adults with COVID-19	31
Sars-Cov-2 antigen tests predict infectivity based on viral culture: comparison of antigen, PCR viral load, and viral culture testing on a large sample cohort	31
Follow-up blood cultures are associated with improved outcome of patients with gram-negative bloodstream infections: retrospective observational cohort study	30
SARS-CoV-2 antibody dynamics and B-cell memory response over time in COVID-19 convalescent subjects	30
Recommendations for accurate genotyping of SARS-CoV-2 using amplicon-based sequencing of clinical samples	30
Antimicrobial stewardship in the emergency department: characteristics and evidence for effectiveness of interventions	30
Time to blood culture positivity in Staphylococcus aureus bacteraemia to determine risk of infective endocarditis	30
Diagnostic challenges of central nervous system infection: extensive multiplex panels versus stepwise guided approach	30
Sample pooling for SARS-CoV-2 RT-PCR screening	30
Proton pump inhibitor use and risk for recurrent Clostridioides difficile infection: a systematic review and meta-analysis	30
Spreading of a new SARS-CoV-2 N501Y spike variant in a new lineage	30
A novel approach for tuberculosis diagnosis using exosomal DNA and droplet digital PCR	30